Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)

SHA:601607 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	288,079	283,580	275,251	260,295	231,981	215,824
Revenue Growth	4.43%	3.03%	5.75%	12.21%	7.49%	12.46%
Gross Profit Gross Profit Growth	31,209	30,373	30,413	30,929	30,377	28,408
Operating Income Operating Income Growth	8,811	8,463	9,317	8,581	8,164	7,466
Net Income Net Income Growth	5,809	5,725	4,553	3,768	5,617	5,093
Earnings Per Share EPS Growth	1.56	1.54	1.23	1.02	1.61	1.79
EPS Growth	33.60%	25.30%	20.73%	-36.77%	-10.06%	13.29%

Revenue by Segment

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Production Production Growth	24,522	23,731	26,257	26,758	25,098
Distribution Distribution Growth	258,828	251,167	233,760	205,733	190,617
Retail Retail Growth	8,666	8,514	9,111	8,264	7,768
Others Others Growth	1,697	1,753	1,816	1,349	1,310
Elimination Elimination Growth	-10,134	-9,915	-10,648	-10,122	-8,969
Total Total Growth	283,580	275,251	260,295	231,981	215,824

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	41,117	43,083	44,377	40,670	37,015	22,390
Total Debt Total Debt Growth	58,835	57,224	54,664	51,911	44,602	40,762
Net Cash (Debt) Net Cash Growth	-17,718	-14,141	-10,287	-11,241	-7,587	-18,372
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-4.78	-3.81	-2.78	-3.04	-2.18	-6.46

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	7,349	6,154	5,827	5,232	4,743	5,061
Capital Expenditures CapEx Growth	-2,283	-2,326	-2,401	-2,971	-2,685	-4,119
Free Cash Flow Free Cash Flow Growth	5,066	3,828	3,426	2,261	2,058	942.55
Free Cash Flow Growth	-25.91%	11.73%	51.55%	9.83%	118.40%	-75.42%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	10.83%	10.71%	11.05%	11.88%	13.10%	13.16%
Operating Margin	3.06%	2.98%	3.38%	3.30%	3.52%	3.46%
Pretax Margin	3.50%	3.46%	2.91%	2.71%	3.80%	3.77%
Profit Margin	2.02%	2.02%	1.65%	1.45%	2.42%	2.36%
FCF Margin	1.76%	1.35%	1.24%	0.87%	0.89%	0.44%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.470	0.470	0.370	0.410	0.610	0.420
Dividend Per Share Growth	62.07%	27.03%	-9.76%	-32.79%	45.24%	-12.50%
Dividend Yield	2.79%	2.71%	1.84%	2.62%	3.77%	2.39%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	10.79	10.34	15.24	14.89	10.69	9.68
Forward PE	11.97	22.12	22.41	8.08	14.04	10.35
P/FCF Ratio	11.16	15.47	20.25	24.82	29.18	52.28
PS Ratio	0.20	0.21	0.25	0.22	0.26	0.23

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 1, 2026

Data Sources Report a data error